Adhesion molecules as therapeutic targets for autoimmune diseases and transplant rejection - PubMed (original) (raw)
Review
Adhesion molecules as therapeutic targets for autoimmune diseases and transplant rejection
Russell L Dedrick et al. Expert Opin Biol Ther. 2003 Feb.
Abstract
Inflammatory disorders such as autoimmune diseases and graft rejection are mediated by activated leukocytes, particularly T lymphocytes, which penetrate the inflamed tissue and perpetuate or amplify the immune reaction. In an unstimulated state, leukocytes do not readily adhere to the vascular endothelium. However, inflammatory signals induce the expression of proteins on the endothelial cell surface that promote the adhesion and extravasation of activated immune cells from the circulation into the underlying tissues. Key among these molecules are P- and E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) on the endothelial cells, and their respective counter receptors, P-selectin glycoprotein ligand-1 (PSGL-1), leukocyte function-associated antigen-1 (LFA-1) and very late antigen-4 (VLA-4), on the leukocytes. In vitro blockade of these molecules inhibits the adhesion of leukocytes. In many cases there is attenuation of leukocyte activation as well. Adhesion blockade in animal models prevents or ameliorates graft rejection and disease severity in autoimmune models. Clinical studies with humanised monoclonal antibodies which interfere with LFA-1/ICAM-1 or VLA-4/VCAM-1 interactions have shown significant efficacy and good safety profiles in autoimmune disease, including psoriasis, multiple sclerosis and inflammatory bowel disease. Thus, adhesion blockade is emerging as a useful therapeutic strategy in several inflammatory settings.
Similar articles
- Cell adhesion molecules in the development of inflammatory infiltrates in giant cell arteritis: inflammation-induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions.
Cid MC, Cebrián M, Font C, Coll-Vinent B, Hernández-Rodríguez J, Esparza J, Urbano-Márquez A, Grau JM. Cid MC, et al. Arthritis Rheum. 2000 Jan;43(1):184-94. doi: 10.1002/1529-0131(200001)43:1<184::AID-ANR23>3.0.CO;2-N. Arthritis Rheum. 2000. PMID: 10643715 - Distinct expression of cell-cell and cell-matrix adhesion molecules on endothelial cells in human heart and lung transplants.
Steinhoff G, Behrend M, Richter N, Schlitt HJ, Cremer J, Haverich A. Steinhoff G, et al. J Heart Lung Transplant. 1995 Nov-Dec;14(6 Pt 1):1145-55. J Heart Lung Transplant. 1995. PMID: 8719462 - Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands.
Marazuela M, Postigo AA, Acevedo A, Díaz-González F, Sanchez-Madrid F, de Landázuri MO. Marazuela M, et al. Eur J Immunol. 1994 Oct;24(10):2483-90. doi: 10.1002/eji.1830241034. Eur J Immunol. 1994. PMID: 7523142 - Basic aspects of neuroimmunology as they relate to immunotherapeutic targets: present and future prospects.
Dalakas MC. Dalakas MC. Ann Neurol. 1995 May;37 Suppl 1:S2-13. doi: 10.1002/ana.410370703. Ann Neurol. 1995. PMID: 8968213 Review. - Adhesion molecules in autoimmune disease.
McMurray RW. McMurray RW. Semin Arthritis Rheum. 1996 Feb;25(4):215-33. doi: 10.1016/s0049-0172(96)80034-5. Semin Arthritis Rheum. 1996. PMID: 8834012 Review.
Cited by
- Blood transcriptomic differences in the immune response under stressful environmental according to stocking density in pigs.
Lim SW, Jeon JH, Lim B, Jang MJ, Kim DH, Kim CH, Kim JM. Lim SW, et al. J Anim Sci. 2023 Jan 3;101:skad336. doi: 10.1093/jas/skad336. J Anim Sci. 2023. PMID: 37798138 Free PMC article. - Pathogenic TNF-α drives peripheral nerve inflammation in an Aire-deficient model of autoimmunity.
Wang Y, Guo L, Yin X, McCarthy EC, Cheng MI, Hoang AT, Chen HC, Patel AY, Allard Trout D, Xu E, Yakobian N, Hugo W, Howard JF Jr, Sheu KM, Hoffmann A, Lechner MG, Su MA. Wang Y, et al. Proc Natl Acad Sci U S A. 2022 Jan 25;119(4):e2114406119. doi: 10.1073/pnas.2114406119. Proc Natl Acad Sci U S A. 2022. PMID: 35058362 Free PMC article. - Delivery of therapeutic agents and cells to pancreatic islets: Towards a new era in the treatment of diabetes.
Zeynaloo E, Stone LD, Dikici E, Ricordi C, Deo SK, Bachas LG, Daunert S, Lanzoni G. Zeynaloo E, et al. Mol Aspects Med. 2022 Feb;83:101063. doi: 10.1016/j.mam.2021.101063. Epub 2021 Dec 24. Mol Aspects Med. 2022. PMID: 34961627 Free PMC article. Review. - Influence of treatments on cell adhesion molecules in patients with systemic lupus erythematosus and rheumatoid arthritis: a review.
da Rosa Franchi Santos LF, Costa NT, Maes M, Simão ANC, Dichi I. da Rosa Franchi Santos LF, et al. Inflammopharmacology. 2020 Apr;28(2):363-384. doi: 10.1007/s10787-019-00674-6. Epub 2019 Dec 9. Inflammopharmacology. 2020. PMID: 31820195 Review. - Renal Allograft Rejection: Noninvasive Ultrasound- and MRI-Based Diagnostics.
Jehn U, Schuette-Nuetgen K, Kentrup D, Hoerr V, Reuter S. Jehn U, et al. Contrast Media Mol Imaging. 2019 Apr 10;2019:3568067. doi: 10.1155/2019/3568067. eCollection 2019. Contrast Media Mol Imaging. 2019. PMID: 31093027 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous